phlow

About phlow

Phlow Corp. is a U.S.-based startup that aims to revolutionize the pharmaceutical supply chain by focusing on the domestic production of Active Pharmaceutical Ingredients (APIs) and Finished Drug Products (FDPs). The company operates as a next-generation Contract Development and Manufacturing Organization (CDMO), providing research and development services for APIs and key starting materials. By doing so, Phlow seeks to streamline supply chains, reduce costs, and enhance the quality of essential medicines.

Phlow's primary clients include government agencies, healthcare providers, and pharmaceutical companies that require a reliable and resilient supply of critical medications. The company operates in the pharmaceutical and healthcare market, which has been historically dependent on foreign manufacturing for APIs. This dependency has led to vulnerabilities such as supply chain disruptions, price surges, and delays in foreign inspections.

Phlow's business model is built around creating a robust domestic supply chain for essential medicines. The company collaborates closely with the U.S. government to ensure a steady and secure supply of critical drugs, thereby mitigating risks associated with global supply chain disruptions. Phlow generates revenue through contracts with government entities and partnerships with healthcare providers and pharmaceutical companies. These contracts often involve the development, manufacturing, and supply of essential medications.

In addition to its core business, Phlow has earned B Corp Certification, underscoring its commitment to improving the quality, reliability, and accessibility of essential medicines. This certification highlights the company's dedication to social and environmental performance, accountability, and transparency.